Cargando…
RON, ROR1 and SUSD2 expression in tissues of endometrial carcinoma patients. Clinicopathological and prognostic implications
INTRODUCTION: Endometrial carcinoma is now considered a common female gynecologic cancer with increasing incidence, with 13–25% of patients being still liable to recurrence and metastasis, which needs further studies to detect novel targets and new therapies. The aim of the study was evaluate tissue...
Autores principales: | Abdelbary, Abeer M., Kaf, Randa Mohamed, Lashin, Mohamed Elbakry, Alattar, Ahmed Z., Elsayed, Dalia Hamouda, Amin, Ahmed F., Gertallah, Loay M., Yehia, Ahmed Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319185/ https://www.ncbi.nlm.nih.gov/pubmed/35903204 http://dx.doi.org/10.5114/wo.2022.118245 |
Ejemplares similares
-
MIR-379-5p Expression in Endometrial Cancer and Its Correlation with ROR1 Expression
por: Mosaada, Hala, et al.
Publicado: (2023) -
In Vitro Implantation Model Using Human Endometrial SUSD2(+)
por: Rahimipour, Marzieh, et al.
Publicado: (2021) -
Downregulation of endometrial mesenchymal marker SUSD2 causes cell senescence and cell death in endometrial carcinoma cells
por: Zhang, Shaqiu, et al.
Publicado: (2017) -
Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study
por: Abuderman, Abdulwahab A., et al.
Publicado: (2020) -
Role of RONS and eIFs in Cancer Progression
por: Salaheldin, Yasmeen Ahmed, et al.
Publicado: (2021)